
	Adam E. Logal has served as OPKO&rsquo;s Senior Vice President and Chief Financial Officer since April 2014 and as OPKO&rsquo;s Chief Accounting Officer and Treasurer since March 2007.

	&nbsp;

	From 2002 to 2007, Mr. Logal served in senior management of Nabi Biopharmaceuticals, a publicly traded, biopharmaceutical company engaged in the development and commercialization of proprietary products.

	&nbsp;

	Mr. Logal held various positions of increasing responsibility, last serving as Senior Director of Accounting and Reporting.
